We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Exploiting the Tumor Microenvironment for Cancer Therapeutics

Article   May 21, 2018 | by Joanna Owens, PhD, Freelance Writer and Editor, UK

 
Exploiting the Tumor Microenvironment for Cancer Therapeutics
 
 
 

RELATED ARTICLES

UHPLC- Robust Technology Built to Perform

Article

Chromatography is the backbone of analytical laboratories with high performance liquid chromatography (HPLC) representing the largest portion. Classical HPLC has been challenged - or complemented - in the last decade by ultrahigh performance liquid chromatography (UHPLC).

READ MORE

Cancer Cells vs Normal Cells

Article

This article outlines some of the key differences between cancer cells and normal cells.

READ MORE

Optimizing Starting Material Quality for Cellular Therapeutics

Article

When a company strives to make an excellent product, they start with the highest quality materials. Cell therapy is unique in that the building blocks for the “product” are living human cells; since each donor is unique, variability is inevitable. Choosing optimal apheresis instrumentation and collection methods is one of the most important steps in ensuring high-quality starting material.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE